• AI-Powered Discovery of Senolytics: New Tools for Targeting

  2026-07-06

  This study presents a machine learning approach to identify novel senolytic compounds, validated through rigorous in vitro testing. The findings demonstrate both the efficiency and scientific impact of AI-driven drug discovery for eliminating senescent cells, with broad implications for cancer and aging research.

• Jasplakinolide: Mechanistic Precision for Translational Disc

  2026-07-06

  Jasplakinolide, a marine-derived cyclodepsipeptide, is revolutionizing actin cytoskeleton research with its potent actin polymerization and filament-stabilizing properties. This thought-leadership article explores the mechanistic underpinnings of Jasplakinolide, critically evaluates its role as an actin polymerization inducer in translational research, and provides strategic guidance for experimental design. We bridge foundational cell biology with forward-looking translational opportunities, referencing APExBIO's Jasplakinolide and positioning it within a competitive landscape, while drawing methodological lessons from chemical genetics approaches in plant hormone signaling.

• Streamlining STING Assays with 2'3'-cGAMP (sodium salt) SKU

  2026-07-05

  This article delivers scenario-driven guidance for optimizing cell-based assays involving STING-mediated innate immune responses using 2'3'-cGAMP (sodium salt) (SKU B8362). Drawing on recent literature and best practices, we address laboratory challenges around assay reproducibility, delivery efficiency, and type I interferon induction, highlighting how APExBIO's offering supports reliable, high-sensitivity workflows.

• Danazol in Bench Research: Applied Protocols & Troubleshooti

  2026-07-04

  Danazol (Danocrine) stands out as a precise tool for modeling steroidogenesis and androgen receptor signaling in translational research. Explore advanced protocols, troubleshooting tips, and unique insights from recent studies, including novel applications in puberty and endocrine modulation.

• Lipid Nanoparticle Delivery of 2'3'-cGAMP Suppresses Pancrea

  2026-07-03

  A recent study demonstrates that encapsulating 2'3'-cGAMP in lipid nanoparticles significantly enhances its cellular delivery and anti-tumor efficacy in pancreatic cancer models. This approach addresses longstanding challenges in activating the STING-mediated innate immune response within immunologically 'cold' tumors, offering a promising direction for immunotherapy research.

• BMS-345541 Hydrochloride: Precision IKK Inhibitor Workflows

  2026-07-03

  BMS-345541 hydrochloride empowers researchers to dissect inflammatory and apoptotic pathways with high selectivity, minimal off-target effects, and robust in vitro/in vivo utility. Discover actionable workflows, troubleshooting strategies, and translational insights that set this IKK inhibitor apart in inflammation and cancer biology research.

• Tofacitinib (CP-690550): Disrupting Cytokine Signaling in RA

  2026-07-02

  Explore how Tofacitinib (CP-690550) uniquely disrupts cytokine signaling and restores mitochondrial function in rheumatoid arthritis models. This article offers a mechanistic deep-dive and practical guidance for advanced immune modulation research.

• DiscoveryProbe Natural Product Library Plus: Accelerating An

  2026-07-02

  The DiscoveryProbe Natural Product Library Plus empowers antiparasitic drug discovery with a rigorously validated, diverse set of cell-permeable bioactive compounds. Researchers can rapidly identify selective inhibitors and activators for challenging targets—like Cryptosporidium parvum’s AdhE—using high-throughput, reproducible workflows. Streamlined deployment, robust QC, and published use-cases set this natural product library apart.

• Inducing Embryonic Dormancy In Vitro via mTOR Inhibition Pro

  2026-07-01

  The reference study establishes a detailed, noninvasive protocol to induce a reversible diapause-like state in mammalian early embryonic cells through pharmacological inhibition of mTOR. This innovation enables scalable and ethically accessible research into dormancy mechanisms, with broad implications for developmental biology and assisted reproduction.

• Oleic Acid (C18:1(9Z)) in Lipid Metabolism Research Workflow

  2026-07-01

  Oleic Acid (C18:1(9Z)) is a cornerstone for modeling lipid metabolism and inflammatory signaling in both in vitro and in vivo systems. This article delivers actionable workflows, troubleshooting strategies, and context-driven innovations for maximizing APExBIO’s high-purity Oleic Acid (C4977) in advanced metabolic and inflammation research.

• Canagliflozin Hemihydrate: Precision Tools for Pathway-Speci

  2026-06-30

  Explore how Canagliflozin hemihydrate enables advanced, pathway-specific glucose metabolism research. This article uniquely examines both the compound's rigorous biochemical properties and the scientific boundaries defined by new mTOR pathway screening technologies.

• Mycophenolic Acid: Mechanistic Powerhouse in Immunometabolis

  2026-06-30

  This article offers translational researchers a deep dive into the mechanistic underpinnings and experimental best practices of using mycophenolic acid, a potent dehydrogenase inhibitor, for immunometabolism research. It bridges protocol-level detail with strategic guidance by synthesizing standardized assay advances and competitive positioning, referencing both foundational literature and practical workflow resources. Distinct from standard product pages, this thought-leadership piece empowers scientists to elevate immune response modulation studies with protocol precision and translational insight.

• SC 79: Unlocking Cytosolic Akt Activation for Advanced Neuro

  2026-06-29

  Explore the unique capabilities of SC 79 as a potent Akt activator, delving into its distinct cytosolic mechanism and neuroprotective potential. This article uniquely analyzes SC 79’s role in Akt signaling pathway research, bridging recent mechanistic discoveries to practical assay design.

• Berberine Modulates RXRα/PPARγ/NEDD4 to Inhibit SASP in Athe

  2026-06-29

  This study uncovers how berberine suppresses senescence-associated secretory phenotype (SASP)-driven inflammation in atherosclerosis by targeting the RXRα/PPARγ/NEDD4 pathway. The mechanistic findings highlight new directions for modulating inflammatory aging and suggest research avenues for dissecting PPARγ signaling.

• Anti-Inflammatory and Anti-Angiogenic Stent Suppresses TISR

  2026-06-28

  Zhao et al. introduce a dual-functional airway stent that integrates anti-inflammatory and anti-angiogenic mechanisms to effectively reduce tracheal in-stent restenosis (TISR) in animal models. This innovative approach demonstrates significant reduction in fibrosis, angiogenesis, and infection, offering a promising strategy for improving airway stent outcomes.

16432 records 1/1096 page Next 12345 下5页 Last page